Skip to content

Price / sales at other companies

3M logo
3MMMM
-0.2×
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
2,438.2×+2,279×
Biogen logo
BiogenBIIB
2.7×+0.7×
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
6.6×+2.1×
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
2.7×-1.9×
Entegris logo
EntegrisENTG
5.5×+1.4×

Other financials

Income statement

See full
Revenue$200.5M+5.2%
Gross profit$64.6M+13.3%
Operating income$10.7M+3,667%
Net income$4.5M+421%
EPS (diluted)$0.25+413%

Balance sheet

See full
Cash & equivalents$195.8M+11.5%
Total debt$29.8M-10.5%
Total equity$1.2B-6.1%
Total assets$1.4B-5.6%

Cash flow

See full
Operating cash flow$5.8M-50.4%
CapEx$4.7M-51.0%
Free cash flow$1.1M-47.6%

Valuation

See full
Market cap$2.84B+53.1%
Enterprise value$2.67B+57.7%

Profitability

See full
Gross margin32.2%-0.7pp
Operating margin8.1%-6.7pp
Net margin-7.4%-9.5pp
FCF margin8.5%+1.8pp

Returns & leverage

See full
Return on equity-4.9%-6.3pp
Debt / equity0.0×
Current ratio+0.1×

Where this comes from

Calculated from Rogers Corporation’s reported figures.

Based on the most recent quarter.

The official record: Rogers Corporation’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rogers Corporation's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rogers Corporation's price / sales?
Rogers Corporation (ROG) reported price / sales of 2.3× in Q1 2026.
How has Rogers Corporation's price / sales changed year-over-year?
Rogers Corporation's price / sales increased by 50.5% year-over-year, from 1.5× to 2.3×.
What is the long-term trend for Rogers Corporation's price / sales?
Over 5 years (2020 to 2025), Rogers Corporation's price / sales has grown at a -10.9% compound annual growth rate (CAGR), from 3.6× to 2×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.